pirfenidon teva 267 mg filmsko obložene tablete
pirfenidon - filmsko obložena tableta - pirfenidon 267 mg / 1 tableta - pirfenidon
pirfenidon teva 801 mg filmsko obložene tablete
pirfenidon - filmsko obložena tableta - pirfenidon 801 mg / 1 tableta - pirfenidon
pulmicort turbuhaler 200 mikrogramov/vdih prašek za inhaliranje
astrazeneca ab - budezonid - prašek za inhaliranje - budezonid 200 µg / 1 vdih - budezonid
pulmicort turbuhaler 400 mikrogramov/vdih prašek za inhaliranje
astrazeneca uk limited - budezonid - prašek za inhaliranje - budezonid 400 µg / 1 vdih - budezonid
pulmicort turbuhaler 100 mikrogramov/vdih prašek za inhaliranje
astrazeneca uk limited - budezonid - prašek za inhaliranje - budezonid 100 µg / 1 vdih - budezonid
esbriet
roche registration gmbh - pirfenidone - idiopathic pulmonary fibrosis; lung diseases; respiratory tract diseases - imunosupresivi - esbriet is indicated in adults for the treatment of idiopathic pulmonary fibrosis.
nulojix
bristol-myers squibb pharma eeig - belatacept - graft rejection; kidney transplantation - imunosupresivi - nulojix, in combination with corticosteroids and a mycophenolic acid (mpa), is indicated for prophylaxis of graft rejection in adult recipients of a renal transplant.
pirfenidone axunio (previously pirfenidone aet)
axunio pharma gmbh - pirfenidone - idiopatska pljučna fibroza - imunosupresivi - pirfenidone aet is indicated in adults for the treatment of mild to moderate idiopathic pulmonary fibrosis (ipf).
pirfenidone viatris
viatris limited - pirfenidone - idiopathic pulmonary fibrosis; lung diseases; respiratory tract diseases - imunosupresivi - pirfenidone viatris is indicated in adults for the treatment of mild to moderate idiopathic pulmonary fibrosis (ipf).
atacand 16 mg tablete
astrazeneca ab - cileksetilkandesartanat - tableta - cileksetilkandesartanat 16 mg / 1 tableta - kandesartan